2025 International Congress » Spasticity

Meeting: 2025 International Congress

Characteristics of IncobotulinumtoxinA Treatment for Limb Spasticity in a Real-World Setting: Dosing and Muscles Injected

J. Holmes, A. Kong, G. Askin, D. Nomah, D. Joseph, K. Biney, M. Hast (Raleigh, USA)

Hemimasticatory Spasm: A Report of Two Cases

X. Xing, N. Ren, . Tang, L. Chen (Tianjin, China)

Hypersensitivity Reaction to Abobotulinumtoxin: A Case Report

T. Le, M. Christie (Houston, USA)

Patient-reported Symptoms and their Impact in Hereditary Spastic Paraplegia and Spastic Ataxias

M. Ademi, C. Dubec-Fleury, J. Morales Saute, J. Greenfield, R. Wallis, C. Gobeil, L. Renna Linton, A. Nadke, R. Horvath, F. Santorelli, B. de Warrenburg, M. Synofzik, S. Du Montcel, P. Consortium, R. Schüle (Heidelberg, Germany)

Spastic Paraplegia as a Novel Phenotype in Late Adulthood Onset POLG Disease: A Pathophysiological Continuum?

S. Jha, M. Jog (London, Canada)

The identification of two novel intronic variants of the SPG4/SPAST gene with pathogenic effect reveals a novel genotype-phenotype correlation

A. Orlacchio, C. Evangelisti, M. Stasi, A. Meyyazhagan, P. Basavaraju, G. Ribas, N. Fava, S. Ramadan, M. Miele, R. Miyamoto, J. Pedroso, O. Barsottini, H. Teive, E. Panza (Bologna, Italy)

« View all sessions from the 2025 International Congress.